Sign in

CIK 0001724521

  • Large accelerated filer

Arcus Biosciences, Inc.

Sign in to watch
Ticker
RCUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473898435
Phone
+1 510-694-6200
Business address
3928 POINT EDEN WAY, HAYWARD, CA, 94545
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$84,810
in 1 filing, $85K under 10b5-1 plans

Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Azoy Alexander −$85K Chief Accounting Officer sold 7% of stake

Reading 59 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-11 Goeltz II Robert C. Chief Financial Officer Sale 10b5-1 −7,763 $25.63 $199K 84,161
2026-01-23 Goeltz II Robert C. Chief Financial Officer Grant or award +24,000 91,924
2026-01-23 Goeltz II Robert C. Chief Financial Officer Grant or award · Stock Option (right to buy) +96,000 96,000
2025-12-31 Goeltz II Robert C. Chief Financial Officer Sale 10b5-1 −6,552 $23.38 $153K 67,924
2025-12-17 Goeltz II Robert C. Chief Financial Officer Sale 10b5-1 −5,960 $22.16 $132K 74,476
2025-12-16 Goeltz II Robert C. Chief Financial Officer Sale 10b5-1 −6,702 $21.88 $147K 80,436
2025-11-26 Goeltz II Robert C. Chief Financial Officer Sale 10b5-1 −5,000 $25.00 $125K 87,138
2025-10-28 Goeltz II Robert C. Chief Financial Officer Sale 10b5-1 −5,000 $20.00 $100K 92,138
2025-01-23 Goeltz II Robert C. Chief Financial Officer Grant or award +37,000 97,138
2025-01-23 Goeltz II Robert C. Chief Financial Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2024-12-31 Goeltz II Robert C. Chief Financial Officer Sale 10b5-1 −3,594 $15.00 $54K 60,138
2024-12-15 Goeltz II Robert C. Chief Financial Officer Shares withheld for taxes −10,099 $16.08 $162K 63,732
2024-01-23 Goeltz II Robert C. Chief Financial Officer Grant or award +22,000 73,831
2024-01-23 Goeltz II Robert C. Chief Financial Officer Grant or award +21,300 73,131
2024-01-23 Goeltz II Robert C. Chief Financial Officer Grant or award · Stock Option (right to buy) +86,600 86,600
2024-01-02 Goeltz II Robert C. Chief Financial Officer Sale 10b5-1 −2,004 $20.00 $40K 51,831
2023-12-19 Goeltz II Robert C. Chief Financial Officer Returned to the company 10b5-1 −2,808 $18.09 $51K 53,835
2023-12-18 Goeltz II Robert C. Chief Financial Officer Returned to the company 10b5-1 −2,749 $17.74 $49K 56,643
2023-06-07 Goeltz II Robert C. Chief Financial Officer Sale 10b5-1 −4,049 $20.04 $81K 59,392
2023-01-23 Goeltz II Robert C. Chief Financial Officer Grant or award +34,000 63,441

Page 1 of 2 · 33 trades